¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Gout polyclonal anti-rabbit antibody"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® gout ÇÑ±Û Åëdz
¼³¸í   
  À¯ÀüÁ¤º¸¸¦ º¸°üÇϴ ¹°ÁúÀΠDNA¿Í RNA µîÀ» ÀÌ·ç´Â ÇÙ»êÀº ¿ä»êÀÇ ÇüÅ·Π¹è¼³ÀÌ µÈ´Ù. À̰ÍÀÇ ¹è¼³¿¡´Â ¿©·¯ °¡Áö È¿¼Ò°¡ ÀÛ¿ëÇÑ´Ù. ÀÌÁß¿¡¼­ HGPRT (Hypoxanthine-Guanine Phosphoribosyl Transferase)¶ó´Â È¿¼Ò´Â À̹̠¹è¼³ÀÌ µÇ·Á°í ¿ä»êÀ¸·Î º¯È¯Çϴ °úÁ¤ÀÇ ¹°ÁúÀ» ´Ù½Ã ÇÙ»êÀ¸·Î ¹Ù²Ù´Â ÀÛ¿ëÀ» Çϴ ȿ¼ÒÀÌ´Ù. ÅëdzÀ̶õ ÀÌ HGPRT¶ó´Â È¿¼Ò È°¼ºµµ°¡ °¨¼ÒµÇ¾î ¹ß»ýµÈ´Ù. ÀÌ È¿¼ÒÀǠȰ¼ºµµ°¡ °¨¼ÒµÇ¸é ÇÙ»êÀÇ ¹è¼³´Ü°è¿¡¼­ Àç»ç¿ëÀ̶ó´Â ´Ü°è°¡ ¾ø¾îÁö¹Ç·Î °úµµÇÑ ¿ä»êÀÇ »ý¼ºÀÌ ÀÖ°Ô µÈ´Ù. Ç÷Áß¿¡ °úµµÇÑ ¿ä»êÀÌ Á¸ÀçÇϰí ÀÌ ¿ä»êÀº °áÁ¤À» ¸¸µé¾î¼­ °üÀý ÁÖÀ§ ¹× ¿¬ºÎ Á¶Á÷¿¡ Ä§ÂøµÇ¾î °Ý½ÉÇÑ ¹ßÀÛ¼º °üÀýÅëÀ» ¾ß±âÇϴ ±Þ¼º ¿°Áõ¼º °üÀý¿°À» ÀÏÀ¸Å°´Â Æ¯Â¡ÀûÀΠº´ÀÌ´Ù. ¶Ç ÀÌ ¿ä»êÀÇ °áÁ¤µéÀÌ ÄáÆÏÀ̳ª ½ÉÀå¿¡ ÃàÀûµÇ¾î¼­ ÄáÆÏ ¹× ½ÉÇ÷°ü°è¿¡ Àå¾Ö°¡ ¹ß»ýÇÒ ¼öµµ À־»°úÀû Ä¡·á¸¦ ¿äÇϴ º´ÀÌ´Ù. À¯Àü ¾ç½Ä»ó º¸Åë¿°»öü ¿ì¼ºÀ¸·Î À¯ÀüÇϴ À¯Àüº´ÀÌ´Ù. º¸Åë¿°»öü ¿ì¼º À¯ÀüÀ» ÇÏÁö¸¸ ³²ÀÚ¿Í ¿©ÀÚ¿¡¼­ Ç¥Çö·üÀÌ ´Þ¶ó¼­ ³²ÀÚ°¡ 95%ÀÌ»óÀ» Â÷ÁöÇÑ´Ù.
¿µ¹® antiglobulin antibody ÇÑ±Û Çױ۷κҸ°Ç×ü
¼³¸í   
  Ç×ü¿¡ ´ëÇÑ Ç×ü, Áï Æ¯Á¤ Ç×ü¿Í °áÇÕÇÒ ¼ö Àִ Ç×ü. ´ë°³ Àΰ£ÀÇ Ç×ü¸¦ Áã¿¡ ÁÖ»çÇÏ¿© Áã·Î ÇÏ¿©±Ý Àΰ£ Ç×ü¿¡ ´ëÇÑ Ç×ü¸¦ ¸¸µé°Ô ÇÑ´Ù(Áã¿¡ À־´Â Àΰ£ÀÇ Ç×üµµ ¿ÜºÎ¿¡¼­ µé¾î¿Â ¹°ÁúÀ̹ǷÎ). À̰ÍÀº ¿©·¯ °¡Áö ½ÇÇè¿¡¼­ Àΰ£ÀǠƯÁ¤Ç×ü¸¦ °ËÃâÇϴµ¥ ÀÌ¿ëÇÑ´Ù.
¿µ¹® antibody ÇÑ±Û Ç×ü
¼³¸í   
  »ç¶÷ÀÇ ¸ö¿¡¼­ ¸é¿ª¿¡ °ü°èÇϴ ¹°Áú. ¿ÜºÎ¿¡¼­ µé¾î¿Â ¹°Áú°ú ²À ¸Â°Ô °áÇÕÀ» ÇÏ¿©¼­ ±× ¹°ÁúÀÇ »ý¹°ÇÐÀû È°µ¿À» ¾ïÁ¦Çϰųª ÆÄ±«Çϰųª »ç¶÷ÀÇ ´Ù¸¥ ¸é¿ª¼¼Æ÷·Î ÇÏ¿©±Ý °ø°ÝÇϱ⠿ëÀÌÇÏ°Ô ÇØÁִ ±â´ÉÀ» °¡Áö°í ÀÖ´Ù. Ç×ü´Â ¸é¿ª±Û·ÎºÎ¸°À̶ó´Â °ÍÀ¸·Î ÀÌ·ç¾îÁ® ÀÖ°í ±× ÇüÅ¿¡ µû¶ó IgA, IgE, IgG, IgDµîÀ¸·Î ³ª´«´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polyclonal antibody
    ´ÙŬ·ÐÇ×ü
  • polyclonal
    ´ÙŬ·Ð-, ´Ù¼¼Æ÷±º-
  • polyclonal activator
    ´ÙŬ·ÐȰ¼ºÁ¦
  • polyclonal gammopathy
    ´Ù¼¼Æ÷±º°¨¸¶±Û·ÎºÒ¸°º´Áõ
  • polyclonal lymphocytosis
    ´ÙŬ·Ð¸²ÇÁ±¸Áõ°¡(Áõ)
  • abarticular gout
    ºñ°üÀýÅëdz
  • articular gout
    °üÀýÅëdz
  • asthenia gout
    ¹«·ÂÅëdz
  • chalk gout
    ¼®È¸Åëdz
  • gout
    Åëdz
  • irregular gout
    ºñ°üÀýÅëdz
  • interval gout
    °£Çæ±âÅëdz
  • juvenile gout
    ¼Ò¾ÆÅëdz
  • latent gout
    ÀáÀçÅëdz
  • lead gout
    ³³Åëdz
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polyclonal antibody
    ´ÙŬ·ÐÇ×ü
  • gout
    Åëdz
  • tophaceous gout
    °áÀýÅëdz
  • antibody
    Ç×ü
  • anti-double stranded deoxyribonucleic acid antib antibody
    Ç×ÀÌÁß°¡´Úµð¿£¿¡ÀÌÇ×ü
  • anti-dsDNA antibody
    (¢¡anti-double stranded deoxyribonucleic acid antibod) Ç×ÀÌÁß°¡´Úµð¿£¿¡ÀÌÇ×ü
  • anti-Ro antibody
    Ç׾˿ÀÇ×ü
  • anti-Sm antibody
    Ç׿¡½º¿¥Ç×ü
  • anticardiolipin antibody
    Ç×Ä«µð¿À¸®ÇÉÇ×ü
  • antineutrophil cytoplasmic antibody
    Ç×Áß¼º±¸¼¼Æ÷ÁúÇ×ü
  • antinuclear antibody
    Ç×ÇÙÇ×ü
  • antiphospholipid antibody
    Ç×ÀÎÁöÁúÇ×ü
  • antisperm antibody
    Ç×Á¤ÀÚÇ×ü
  • atypical antibody
    ºñÁ¤ÇüÇ×ü
  • autoimmune antibody
    ÀÚ°¡¸é¿ªÇ×ü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polyclonal antibody
    ´ÙŬ·ÐÇ×ü
  • polyclonal activator
    ´ÙŬ·ÐȰ¼ºÁ¦
  • polyclonal gammopathy
    ´Ù¼¼Æ÷±º°¨¸¶±Û·ÎºÒ¸°º´Áõ
  • polyclonal lymphocytosis
    ´ÙŬ·Ð¸²ÇÁ±¸Áõ°¡Áõ
  • abarticular gout
    ºñ°üÀýÅëdz
  • articular gout
    °üÀýÅëdz
  • asthenia gout
    ¹«·ÂÅëdz
  • chalk gout
    ¼®È¸Åëdz
  • gout
    Åëdz
  • interval gout
    °£Çæ±âÅëdz
  • irregular gout
    (¢¡abarticular gout) ºñ°üÀýÅëdz
  • juvenile gout
    ¼Ò¾ÆÅëdz
  • latent gout
    ÀáÀçÅëdz
  • lead gout
    ³³Åëdz
  • masked gout
    (¢¡latent gout) ÀáÀçÅëdz
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polyclonal antibody
    ´ÙŬ·ÐÇ×ü
  • polyclonal antibody
    ´ÙŬ·Ð¼º Ç×ü
  • polyclonal antibody
    ´Ù¼¼Æ÷±ºÇ×ü, ¿©·¯¹«¸®Ç×ü
  • activation, polyclonal
    ´Ù¼¼Æ÷±ºÈ°¼º, ¿©·¯¹«¸®È°¼º
  • activation, polyclonal B cell
    ´Ù¼¼Æ÷±º B¼¼Æ÷Ȱ¼º, ¿©·¯¹«¸® B¼¼Æ÷Ȱ¼º
  • polyclonal
    ´ÙÅ©·Ð(¼º)(¡­àõ)ÀÇ
  • polyclonal
    ´Ù¼¼Æ÷±ºÀÇ, ´Ù[¼ö]Ŭ·ÐÀÇ, ¿©·¯¹«¸®ÀÇ
  • polyclonal B cell activation
    B¼¼Æ÷ ´Ù(¼ö)Ŭ·ÐȰ¼º, B¼¼Æ÷ ¿©·¯¹«¸®È°¼º
  • polyclonal activation
    ´Ù(¼ö)Ŭ·ÐȰ¼º, ¿©·¯¹«¸®È°¼º
  • polyclonal activator
    ´Ù(¼ö)Ŭ·ÐȰ¼ºÁ¦, ¿©·¯¹«¸®È°¼ºÁ¦
  • polyclonal gammopathy
    ´ÙŬ·Ð¼º °¨¸¶±Û·ÎºÒ¸°Àå¾Ö
  • polyclonal immunoglobulin
    ´ÙŬ·Ð¼º¸é¿ª±Û·ÎºÒ¸°
  • polyclonal lymphocytosis
    ´ÙŬ·Ð¼º¸²ÇÁ±¸Áõ°¡Áõ
  • Gout
    Åëdz(÷Ôù¦)
  • abarticular gout
    ºñ°üÀý¼º Åëdz(ުμï½àõ ÷Ôù¦).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polyclonal antibody
    ´ÙŬ·Ð¼º Ç×ü
  • polyclonal antibody
    ´ÙŬ·ÐÇ×ü
  • polyclonal antibody
    ´Ù¼¼Æ÷±ºÇ×ü, ¿©·¯¹«¸®Ç×ü
  • activation, polyclonal
    ´Ù¼¼Æ÷±ºÈ°¼º, ¿©·¯¹«¸®È°¼º
  • activation, polyclonal B cell
    ´Ù¼¼Æ÷±º B¼¼Æ÷Ȱ¼º, ¿©·¯¹«¸® B¼¼Æ÷Ȱ¼º
  • polyclonal
    ´ÙÅ©·Ð(¼º)(¡­àõ)ÀÇ
  • polyclonal
    ´Ù¼¼Æ÷±ºÀÇ, ´Ù[¼ö]Ŭ·ÐÀÇ, ¿©·¯¹«¸®ÀÇ
  • polyclonal B cell activation
    B¼¼Æ÷ ´Ù(¼ö)Ŭ·ÐȰ¼º, B¼¼Æ÷ ¿©·¯¹«¸®È°¼º
  • polyclonal activation
    ´Ù(¼ö)Ŭ·ÐȰ¼º, ¿©·¯¹«¸®È°¼º
  • polyclonal activator
    ´Ù(¼ö)Ŭ·ÐȰ¼ºÁ¦, ¿©·¯¹«¸®È°¼ºÁ¦
  • polyclonal gammopathy
    ´ÙŬ·Ð¼º °¨¸¶±Û·ÎºÒ¸°Àå¾Ö
  • polyclonal immunoglobulin
    ´ÙŬ·Ð¼º¸é¿ª±Û·ÎºÒ¸°
  • polyclonal lymphocytosis
    ´ÙŬ·Ð¼º¸²ÇÁ±¸Áõ°¡Áõ
  • abarticular gout
    ºñ°üÀý¼º Åëdz(ުμï½àõ ÷Ôù¦).
  • articular gout
    °üÀý¼º Åëdz.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gout
    Åëdz(÷×ù¦)
  • polyclonal antibodies
    ´Ù(Òý)Ŭ·Ð Ç×ü(ù÷ô÷)
  • acquired antibody
    "ȹµæÇ×ü (üòÔðù÷ô÷), ÈÄõ¼ºÇ×ü (ý­ô¸àõù÷ô÷)"
  • agglutinating antibody
    ÀÀÁýÇ×ü(ëêó¢ù÷ô÷)
  • anti-idiotype antibody
    Ç×(ù÷)À̵ð¿ÀŸÀÌÇÁ Ç×ü(ù÷ô÷)
  • anti-immunoglobulin antibody
    Ç׸鿪(ù÷Øóæ¹)±Û·ÎºÒ¸° Ç×ü(ù÷ô÷)
  • antibody
    Ç×ü(ù÷ô÷)
  • antibody binding fraction
    Ç×ü°áÇÕºÐȹ (ù÷ô÷Ì¿ùêÝÂüò)
  • antibody combining site
    Ç×ü°áÂø(ù÷ô÷Ì¿ó·)ÀÚ¸®
  • antibody dependent cellular cytotoxicity
    Ç×üÀÇÁ¸ÀÚ¸® ¼¼Æ÷¼º¼¼Æ÷µ¶¼º(ù÷ô÷ëîðíá¬øààõá¬øàÔ¸àõ)
  • antibody diversity
    Ç×ü ´Ù¾ç¼º(ù÷ô÷ÒýåÆàõ)
  • antibody fixation
    Ç×ü °íÁ¤(ù÷ô÷ͳïÒ)
  • antibody formation
    Ç×ü Çü¼º(ù÷ô÷û¡à÷)
  • antibody heterogeneity
    Ç×ü ºÒ±ÕÀϼº(ù÷ô÷ÝÕгìéàõ)
  • antibody mediated hypersensitivity
    Ç×ü ¸Å°³ °ú¹ÎÁõ(ù÷ô÷ØÚ˿ΦÚÂñø)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gout
    Åëdz
  • agglutination antibody titer
    ÀºÁýÇ×ü¿ª°¡
  • antibody
    Ç×ü
  • antigen antibody reaction
    Ç׿øÇ×ü¹ÝÀÀ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PCA para-chloramphetamine; parietal cell antibody; passive cutaneous anaphylaxis; patient care assistant...
ACA abnormal coronary artery; acrodermatitis chronica atrophicans; acute cerebellar ataxia; adenocarcino...
ABC absolute basophil count; absolute bone conduction; acalculous biliary colic; acid balance control; a...
PRAGMATIC pregnancy, rheumatoid arthritis, acromegaly, glucose metabolism disorders, mechanical injury, amyloi...
PBA polyclonal B-cell activity; pressure breathing assist; prolactin-binding assay; prune belly anomaly;...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PAB Polyclonal antibody
PPBL Persistent polyclonal B cell lymphocytosis
PAb Polyclonal
PBA Polyclonal B cell activation
PBA polyclonal B cell activator
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • polyclonal antibody
    ´ÙŬ·Ð¼º Ç×ü
  • polyclonal activation
    ´Ù¼ö Ŭ·Ð Ȱ¼º
  • polyclonal gammopathy
    ´ÙŬ·Ð¼º °¨¸¶ ±Û·ÎºÒ¸° Àå¾Ö
  • polyclonal lymphocytosis
    ´ÙŬ·Ð¼º ¸²ÇÁ±¸ Áõ°¡Áõ
  • abarticular gout
    ºñ°üÀý¼º Åëdz
    °üÀý°ú °ü·ÃÀÌ ¾ø´Â Åëdz.
  • calcium gout
    Ä®½· Åëdz
  • chalk gout
    ¼®È¸ Åëdz
  • juvenile gout
    ¿¬¼Ò¼º Åëdz
  • polyarticular gout
    ´Ù°üÀý¼º Åëdz
  • renal gout
    ½Å¼º Åëdz
  • retrocedent gout
    ³»°ø¼º Åëdz
  • rheumatic gout
    ·ù¸¶Æ¼½º¼º Åëdz
  • agglutination antibody titer
    ÀÀÁý Ç×ü ¿ª°¡
  • albumin agglutinating antibody
    ¾ËºÎ¹Î ÀÀÁý Ç×ü
  • alloimmune antibody
    µ¿Á¾ ¸é¿ª Ç×ü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
polyclonal antibody An antibody produced by several clones of B lymphocytes as would be the case in a whole animal. Usually refers to antibodies raised in immunised animals, whereas a monoclonal antibody is the product of a single clone of B lymphocytes, usually maintained in vitro.
(18 Nov 1997)
polyclonal Derived from different types of cells.
(14 Nov 1997)
polyclonal activator A substance that will activate T-cells, B-cells, or both regardless of their specificities.
(05 Mar 2000)
polyclonal antibodies A group of antibodiesproduced by different B lymphocytes in responseto the same antigen, different antibodies in the group recognise different parts of the antigen.
(09 Oct 1997)
polyclonal antiserum A mixture of antibodies to a variety of antigens or to a variety of determinants on a single antigen.
(09 Oct 1997)
polyclonal compartment When the progeny of several cells occupy an area or volume with a defined boundary, it is referred to as a polyclonal compartment, for example clones lying close to the mid line of the wing of Drosophila.
(18 Nov 1997)
arthritis, gout Joint inflammation caused by uric acid crystal deposits in the joint space An attack is usually extremely painful.The uric acid crystals are deposited in the joint fluid (synovial fluid) and joint lining (synovial lining). Intense joint inflammation occurs as white blood cells engulf the uric acid crystals, causing pain, heat, and redness of the joint tissues. The term gout commonly is used to refer to these painful arthritis attacks but gouty arthritis is only one manifeatation of gout.
(12 Dec 1998)
calcium gout <rheumatology> Chondrocalcinosis, chronic recurrent arthritis clinically similar to gout.
(27 Sep 1997)
masked gout latent gout
retrocedent gout An obsolete term for the occurrence of severe gastric, cardiac, or cerebral symptoms during an attack of gout, especially when the joint and other symptoms suddenly subside at the same time.
Saturnine gout, gout occurring in a person with lead poisoning.
Synonym: lead gout.
Secondary gout, gout resulting from increased serum uric acid levels as a result of an antecedent disease, such as a proliferative disease of the blood and bone marrow, lead poisoning, or prolonged chronic renal failure (on dialysis).
Tophaceous gout, gout in which deposits of uric acid and urates occur as gouty tophi.
(05 Mar 2000)
gout <rheumatology> Recurrent acute arthritis of peripheral joints caused by the accumulation of monosodium urate crytals. Often presents as pain and swelling confined to one joint. The big toe joint is commonly affected.
The arthritis occurs secondary to an inherited abnormality of purine metabolism, resulting in the deposition of uric acid crystals (sodium urate) within the joint space and articular cartilage.
Usually due to overproduction of uric acid but may be a result of under excretion. The problems partly arise because neutrophils release lysosomal enzymes as a result of damage to the phagosome membrane by ingested crystals: colchicine acts to reduce the attack by inhibiting lysosome phagosome fusion.
(18 Nov 1997)
gout arthritis <rheumatology> Recurrent acute arthritis of peripheral joints caused by the accumulation of monosodium urate crytals. Often presents as pain and swelling confined to one joint. The big toe joint is commonly affected.
The arthritis occurs secondary to an inherited abnormality of purine metabolism, resulting in the deposition of uric acid crystals (sodium urate) within the joint space and articular cartilage.
Usually due to overproduction of uric acid but may be a result of under excretion. The problems partly arise because neutrophils release lysosomal enzymes as a result of damage to the phagosome membrane by ingested crystals: colchicine acts to reduce the attack by inhibiting lysosome phagosome fusion.
(18 Nov 1997)
gout diet A diet containing a minimal quantity of purine bases (meats); liver, kidney, and sweetbread especially are excluded and replaced by dairy products, fruits, and cereals; alcoholic beverages also are excluded.
Synonym: purine-free diet.
(05 Mar 2000)
gout suppressants Agents that increase uric acid excretion by the kidney (uricosuric agents), decrease uric acid production (antihyperuricaemics), or alleviate the pain and inflammation of acute attacks of gout.
(12 Dec 1998)
gout, tophaceous A form of chronic gout. Nodular masses of uric acid crystals (tophi) are deposited in different soft tissue areas of the body. Even though tophi are most commonly found as hard nodules around the fingers, at the tips of the elbows, and around the big toe, tophi nodules can appear anywhere in the body. They have been reported in unexpected areas such as in the ears, vocal cords, or around the spinal cord!
(12 Dec 1998)
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 2 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿À¿¡½ºÇ÷¯½º - »õâ
»ïõ´çÁ¦¾à
Gout polyclonal anti-rabbit antibody, Mouse monoclonal anti ¥â-HCG antibody, Rabbit Ig
ÀϹÝÀǾàǰ | ºñ±Þ¿©
¾¾Æ¼¿¥º£À̺ñý - »õâ
»ïõ´çÁ¦¾à
Gout polyclonal anti-rabbit antibody, Mouse monoclonal anti ¥â-HCG antibody, Rabbit Ig
ÀϹÝÀǾàǰ | ºñ±Þ¿©
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gout
    ¸À;Ãë¹Ì
  • gout
    Åëdz;(ƯÈ÷,ÇÇÀÇ)¹æ¿ï;ÀÀÇ÷
  • antibody
    Ç×µ¶¼Ò; Ç×ü
  • antibody
    Ç×µ¶¼Ò;(Ç÷¾× ÁßÀÇ)Ç×ü
  • monoclonal antibody
    ´ÜÀÏ Å¬·Ð Ç×ü
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á